Table 2.
Biological functions of miRNAs in different species
Species | Expression | miRNA | mRNA target | Validation (Expt/Pred) | Mode of regulation | Process regulated | References |
Schizosaccharomyces pombe | — | 12 different small RNAs | Centromeric regions | Expt | H3 K9 DNA methylation | Maintenance of heterochromatin | [135] |
Caenorhabditis elegans | — | lin-4 | lin-14 | Expt | Translational repression/mRNA cleavage | Control of the developmental stages L1-L3 | [3, 4, 75, 151] |
lin-28 | |||||||
— | let-7 | hbl-1 | Expt | Translational repression/mRNA cleavage | Control of the last developmental stage L4 | [75, 149, 152–156] | |
lin-41 | |||||||
daf-12 | |||||||
ras | |||||||
— | miR-48 miR-84 miR-241 | hbl-1 | Expt | Translational repression | Control of the L2 to L3 transition | [157] | |
Drosophila melanogaster | — | bantam | hid | Expt | Translational repression | Inhibition of apoptosis | [158] |
— | miR-2 miR-6 miR-11 miR-13 miR-308 | ND | Expt | ND | Inhibition of apoptosis | [159] | |
Mus musculus | Hematopoietic cells | miR-142 miR-181 miR-223 | ND | Expt | ND | Hematopoietic cell differentiation | [150] |
Mouse embryo < day 7 | miR-196 | HOXB8 | Expt | mRNA cleavage | Control of the developmental program | [74] | |
Homo sapiens | Brain | miR-124 | ND | Expt | ND | Brain-specific gene expression | [73] |
Muscle | miR-1 | ND | Expt | ND | Muscle-specific gene expression | [73] | |
Overexpression in brain tumor glioblastoma | miR-21 | ND | Expt | ND | Inhibition of apoptosis | [160] | |
Downregulation in CLL | miR-15a miR-16-1 | Bcl2 | Expt | Translational repression | Induction of apoptosis | [161, 162] | |
Downregulation in numerous cancer cultured cells | miR-143 miR-145 | ND | Expt | ND | Oncogenesis | [163] | |
Overexpression in BL patient | miR-155 | ND | Expt | ND | Oncogenesis | [164] | |
Overexpression in B-cells lymphomas and lung cancer cell lines | miR-17-92 cluster | ND | Expt | ND | Oncogenesis | [165] | |
HeLa, 293T | miR-32 | ORF2 in the 3′NTR of all remaining PFV-1 mRNAs | Expt | ND | Restriction of PFV-1 accumulation | [166] | |
Liver-specific expression | miR-122 | 5′ noncoding region of the HCV genome | Expt | ND | Facilitation of HCV replication | [167] | |
T cells | miR-29a miR-29b | nef | Pred | ND | Inhibition of HIV-1 replication | [168] | |
T cells | miR-149 | vpr | Pred | ND | Control of the cell cycle arrest in G2 | [168] | |
T cells | miR-378 | env | Pred | ND | Control of the virus assembly | [168] | |
T cells | miR-324-5p | vif | Pred | ND | Control of viral particle production | [168] |
BL: Burkitt lymphoma; CLL: chronic lymphocytic leukemias; Expt: experimental; HCV: hepatitis C virus; HIV-1: human immunodeficiency virus type 1; ND: not determined; PFV-1: primate foamy virus type 1; Pred: predicted.